Supernus to Participate in Two Upcoming Investor Conferences
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that the Supernus Pharmaceuticals management team
By Supernus Pharmaceuticals, Inc.
Published - Mar 08, 2023, 04:14 PM ET
Last Updated - Apr 04, 2024, 03:18 PM EDT
ROCKVILLE, Md., March 08, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that the Supernus Pharmaceuticals management team will participate in the following March investor conferences:
Barclays Global Healthcare Conference
Date: Wednesday, March 15, 2023
Place: Loews Miami Beach Hotel, Miami, Fla.
Jefferies Biotech on the Bay Summit
Date: Thursday, March 16, 2023
Place: The 1 Hotel South Beach, Miami, Fla.
Investors interested in arranging a meeting with the Company's management during these conferences should contact the respective conference coordinators.
